[HTML][HTML] Role of lipid-lowering therapy in peripheral artery disease

AD Belur, AJ Shah, SS Virani, M Vorla… - Journal of Clinical …, 2022 - mdpi.com
Atherosclerosis is a multifactorial, lipoprotein-driven condition that leads to plaque formation
within the arterial tree, leading to subsequent arterial stenosis and thrombosis that accounts …

Identification of neolignans with PCSK9 downregulatory and LDLR upregulatory activities from Penthorum chinense and the potential in cholesterol uptake by …

HS Chae, P Pel, J Cho, YM Kim, CY An, J Huh… - Journal of …, 2021 - Elsevier
Ethnopharmacological relevance Penthorum chinense has been used in East Asia for the
treatment of cholecystitis, infectious hepatitis, jaundice and to treat liver problems. Recent …

[HTML][HTML] Presence of asymptomatic peripheral arterial disease in combination with common risk factors elevates the cardiovascular risk substantially

F Sartipy, AJG Pereira Filho, F Lundin… - International Journal of …, 2022 - Elsevier
Background and aims This study evaluates the risks for adverse cardiovascular (CV) events
in Asymptomatic Peripheral Arterial Disease (APAD) combined with different traditional CV …

Non-coronary Atherosclerotic Arterial Disease: A Where Are We Now?

C Krittanawong, J Escobar, HUH Virk, M Alam… - The American Journal of …, 2023 - Elsevier
Lower extremity peripheral artery and upper extremity artery disease are significant vascular
conditions with distinct clinical presentations and diagnostic and therapeutic approaches …

The real-world data of lipid-lowering treatment in patients with peripheral artery disease and its association with severity of disease

H Komai, M Ogura, H Sakashita, N Miyama… - Journal of …, 2024 - Elsevier
Background The risk of coronary artery disease in peripheral arterial disease (PAD) is high,
life prognosis is poor, and lipid-lowering treatment with statins has been reported to improve …

[HTML][HTML] Lipoprotein Apheresis Alleviates Treatment-Resistant Peripheral Artery Disease Despite the Normal Range of Atherogenic Lipoproteins: The LETS-PAD …

E Ueda, Y Toya, H Wakui, K Ishiga, Y Kawai… - … of Atherosclerosis and …, 2024 - jstage.jst.go.jp
Aim: Peripheral artery disease (PAD) severely impairs patient prognosis and quality of life
(QOL). Although lipoprotein apheresis (LA) has been applied to patients with PAD and …

[PDF][PDF] Clinical characteristics and risk factors of diabetic foot ulcers with PAD.

GL Tao, LS Zheng, ZY Wang, YP Xu… - European Review for …, 2023 - europeanreview.org
OBJECTIVE: This study aimed to analyze the clinical characteristics of patients with diabetic
foot ulcers combined with peripheral arterial disease (PAD) and the risk factors. PATIENTS …

Statin use improves survival of patients with known or suspected lower extremity artery disease on all ankle brachial index levels

M Laivuori, F Biancari, J Sinisalo, A Albäck… - Vasa, 2022 - econtent.hogrefe.com
Background: Statin medication improves the prognosis of patients with lower extremity artery
disease (LEAD). Research has previously focused on patients with a lowered ankle brachial …

A Practical Guide to Understanding and Treating Peripheral Artery Disease

MR Chilbert, AE Woodruff… - Journal of Cardiovascular …, 2022 - journals.lww.com
Peripheral arterial disease (PAD) is the third leading cause of atherosclerotic morbidity after
coronary heart disease and stroke yet is widely underdiagnosed and undertreated …

Update–Lipidsenkende Therapie bei pAVK

KS Mühlberg - DMW-Deutsche Medizinische Wochenschrift, 2023 - thieme-connect.com
Versorgungsrealität Trotz klarer Leitlinienempfehlungen werden nur etwa jedem 2. pAVK-
Patienten Statine verordnet, Frauen zudem seltener als Männern. Die Rate der eingelösten …